Australia markets closed

GSK plc (GSK)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
38.83-0.38 (-0.97%)
At close: 04:00PM EDT
38.79 -0.04 (-0.10%)
After hours: 07:52PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 80.22B
Enterprise value 98.46B
Trailing P/E 13.27
Forward P/E 8.37
PEG ratio (5-yr expected) 1.23
Price/sales (ttm)1.72
Price/book (mrq)4.25
Enterprise value/revenue 2.40
Enterprise value/EBITDA 9.32

Trading information

Stock price history

Beta (5Y monthly) 0.31
52-week change 36.90%
S&P500 52-week change 333.56%
52-week high 345.93
52-week low 333.67
50-day moving average 341.45
200-day moving average 341.23

Share statistics

Avg vol (3-month) 33.93M
Avg vol (10-day) 36.21M
Shares outstanding 52.04B
Implied shares outstanding 62.11B
Float 83.95B
% held by insiders 10.06%
% held by institutions 115.49%
Shares short (30 Sept 2024) 410.36M
Short ratio (30 Sept 2024) 43.03
Short % of float (30 Sept 2024) 4N/A
Short % of shares outstanding (30 Sept 2024) 40.51%
Shares short (prior month 30 Aug 2024) 410.91M

Dividends & splits

Forward annual dividend rate 41.53
Forward annual dividend yield 43.91%
Trailing annual dividend rate 30.60
Trailing annual dividend yield 31.53%
5-year average dividend yield 44.83
Payout ratio 451.97%
Dividend date 310 Oct 2024
Ex-dividend date 416 Aug 2024
Last split factor 21226:1000
Last split date 322 July 2022

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 June 2024

Profitability

Profit margin 12.83%
Operating margin (ttm)28.09%

Management effectiveness

Return on assets (ttm)9.56%
Return on equity (ttm)33.30%

Income statement

Revenue (ttm)31.45B
Revenue per share (ttm)15.47
Quarterly revenue growth (yoy)9.80%
Gross profit (ttm)N/A
EBITDA 10.98B
Net income avi to common (ttm)4.03B
Diluted EPS (ttm)2.93
Quarterly earnings growth (yoy)-27.80%

Balance sheet

Total cash (mrq)2.98B
Total cash per share (mrq)0.73
Total debt (mrq)16.94B
Total debt/equity (mrq)123.04%
Current ratio (mrq)0.82
Book value per share (mrq)3.52

Cash flow statement

Operating cash flow (ttm)7.48B
Levered free cash flow (ttm)5.5B